Faculty profile

Ryan Zarychanski

ResearcherCritical Care MedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Ryan Zarychanski

Researcher

Critical Care Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2024.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,578

Citations

h-index

170

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Trials Covid-19 Network

Latest papers

Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury
New England Journal of Medicine · 2024
Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation
New England Journal of Medicine · 2024
Simvastatin in Critically Ill Patients with Covid-19.
The New England journal of medicine · 2023

All 10 publications

Latest funding

Enabling Bayesian Clinical Trials: Improving the use of Bayesian methods in randomised clinical trials of efficacy and effectiveness
CIHR · 2026 · Co-investigator
$1,143,676
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-Acquired Pneumonia (REMAP-CAP): Enshrining a Global Pandemic Research Response to COVID-19 and Beyond
CIHR · 2022 · Co-investigator
$883,029
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
CIHR · 2022 · Principal investigator
$1,000,000

All 18 grants and awards

10 publications.

Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury

Clayton L, Patton M-P, Walsh TS, Moore L, Laroche V, Greenbaum J, Kramer A, Rey VG, Khwaja K, Wise M

New England Journal of Medicine2024165 citations

DOI: 10.1056/nejmoa2404360

Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation

Iqbal M, Reeve B, Forrest D, Trop S, Reynolds S, Saunders L, Heels-Ansdell D, Marshall J, English S, Ostermann M

New England Journal of Medicine2024108 citations

DOI: 10.1056/nejmoa2404245

Simvastatin in Critically Ill Patients with Covid-19.

REMAP-CAP Investigators, Hills TE, Lorenzi E, Berry LR, Shyamsundar M, Al-Beidh F, Annane D, Arabi Y, Aryal D, Au C, Beane A, Bhimani Z, Bonten M, Bradbury CA, Brunkhorst FM, Burrell A, Buxton M, Calfee CS, Cecconi M, Cheng AC, Cove ME, Detry MA, Estcourt LJ, Fitzgerald M, Goligher EC, Goossens H, Green C, Haniffa R, Harrison DA, Hashmi M, Higgins AM, Horvat C, Huang DT, Ichihara N, Jayakumar D, Kruger PS, Lamontagne F, Lampro L, Lawler PR, Marshall JC, Mason AJ, McGlothlin A, McGuinness S, McQuilten ZK, McVerry BJ, Mouncey PR, Murthy S, Neal MD, Nichol AD, O'Kane CM, Parke RL, Parker JC, Rabindrarajan E, Reyes LF, Rowan KM, Saito H, Santos M, Saunders CT, Seymour CW, Shankar-Hari M, Sinha P, Thompson BT, Turgeon AF, Turner AM, van de Veerdonk F, Weis S, Young IS, Zarychanski R, Lewis RJ, McArthur CJ, Angus DC, Berry SM, Derde LPG, Webb SA, Gordon AC, McAuley DF

The New England journal of medicine2023

DOI: 10.1056/nejmoa2309995 PMID: 37888913

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J

CANADIAN MEDICAL ASSOCIATION JOURNAL2022173 citationsSenior author

DOI: 10.1503/cmaj.211698

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Berry LR, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Buzgau A, Cheng AC, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Lamontagne F, Lawler PR, Leavis HL, Linstrum KM, Litton E, Lorenzi E, Marshall JC, Mayr FB, McAuley DF, McGlothlin A, McGuinness SP, McVerry BJ, Montgomery SK, Morpeth SC, Murthy S, Orr K, Parke RL, Parker JC, Patanwala AE, Pettilä V, Rademaker E, Santos MS, Saunders CT, Seymour CW, Shankar-Hari M, Sligl WI, Turgeon AF, Turner AM, van de Veerdonk FL, Zarychanski R, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Webb SA, Derde LPG

The New England journal of medicine2021

DOI: 10.1056/nejmoa2100433 PMID: 33631065

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Effron MB, Berger JS, Gong MN, Kumar A, Kahn SR, McQuilten Z, Farkouh ME, Brooks MM, Lewis RJ, Berry LR

New England Journal of Medicine2021922 citations

DOI: 10.1056/nejmoa2103417

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Chen J-T, Effron MB, Silva DG, Berger JS, Gong MN, Rosenson RS, Kumar A, Kahn SR, Cushman M, McQuilten Z

New England Journal of Medicine2021894 citations

DOI: 10.1056/nejmoa2105911

The Efficacy and Safety of Heparin in Patients With Sepsis

Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE

Critical Care Medicine2015188 citationsFirst author

DOI: 10.1097/ccm.0000000000000763

Failure of Anticoagulant Thromboprophylaxis

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D

Critical Care Medicine2015128 citations

DOI: 10.1097/ccm.0000000000000713

Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis.

Dennis J, Ramsay T, Turgeon AF, Zarychanski R

BMJ (Clinical research ed.)2013Senior author

DOI: 10.1136/bmj.f2674 PMID: 23674137

Something wrong or missing on this profile? Suggest a correction

Ryan Zarychanski

Research

Latest papers

Latest funding

Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury

Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation

Simvastatin in Critically Ill Patients with Covid-19.

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

The Efficacy and Safety of Heparin in Patients With Sepsis

Failure of Anticoagulant Thromboprophylaxis

Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis.

Frequent collaborators

Ryan Zarychanski

Ryan Zarychanski

Francois Lamontagne

Francois Lamontagne

Srinivas Murthy

Srinivas Murthy

Srinivas Murthy

Srinivas Murthy

Anand Kumar

Gloria Vazquez-Grande

Deborah Cook

Francois Lamontagne

John Marshall

John Muscedere

Maureen Meade

Marc Carrier

Ian Ball

Francois Lamontagne

Sean van Diepen

Sangeeta Mehta

Maureen Meade

Maureen Meade

John Marshall

Gordon Guyatt

Shane English

Alexandra Binnie

Gordon Guyatt

Alison Fox-Robichaud

Jennifer Tsang

Anand Kumar

Nelson Lee

Alexis Turgeon

Menaka Pai

Patrick Archambault

Bram Rochwerg

Yoav Keynan

Michael Fralick

Madeleine Durand

Maude St-Onge

Patrick Archambault